B Boston Scientific Corp.
| Market Cap | $93.36B |
| P/E Ratio | 32.38 |
| Forward P/E | 16.07 |
| Dividend Yield | — |
| Beta | 0.78 |
| 52W Range | $62.00 - $108.14 |
| # Hedge Funds | 7 |
| Sector | Healthcare |
| Industry | Medical Devices |
Hedge Fund Ownership
| Investor 7 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| John Armitage Egerton Capital | 5.58% | $513.47M | 5,385,084 | Add 1.37% |
| Lee Ainslie Maverick Capital | 3.01% | $280.73M | 2,944,254 | Buy |
| Polen Capital Management Polen Capital Management | 1.64% | $383.26M | 4,019,552 | Reduce 28.20% |
| Viking Global Investors Viking Global Investors | 0.64% | $239.31M | 2,509,808 | Reduce 4.99% |
| Stephen Mandel Lone Pine Capital | 0.14% | $19.23M | 201,703 | Buy |
| Mairs & Power Growth Fund Mairs & Power Inc | 0.01% | $970.00K | 10,176 | Reduce 1.27% |
| Dodge & Cox Dodge & Cox | 0.00% | $8.47M | 88,885 | — |
Insider Trading
| Insider Name of the company insider who made the trade 18 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Mahoney Michael FChairman, President & CEO | Sale | 1,200 | $94.06 | $112.87K | 02 Feb 2026 | 03 Feb 2026 |
| Mahoney Michael FChairman, President & CEO | Sale | 159,701 | $93.49 | $14.93M | 02 Feb 2026 | 03 Feb 2026 |
| Michael F MahoneyChairman, President & CEO | Sale | 159,701 | $93.49 | $14.93M | 02 Feb 2026 | 03 Feb 2026 |
| Michael F MahoneyChairman, President & CEO | Sale | 1,200 | $94.06 | $112.87K | 02 Feb 2026 | 03 Feb 2026 |
| Butcher Arthur CEVP& Grp Pres, MedSurg & APAC | Sale | 17,313 | $101.55 | $1.76M | 01 Dec 2025 | 02 Dec 2025 |
| Arthur C ButcherEVP& Grp Pres, MedSurg & APAC | Sale | 17,313 | $101.55 | $1.76M | 01 Dec 2025 | 02 Dec 2025 |
| Zane Ellen M | Sale | 12,891 | $98.28 | $1.27M | 06 Nov 2025 | 06 Nov 2025 |
| Ellen M ZaneDirector | Sale | 12,891 | $98.28 | $1.27M | 06 Nov 2025 | 06 Nov 2025 |
| Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sale | 29,472 | $99.14 | $2.92M | 03 Nov 2025 | 04 Nov 2025 |
| Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sale | 16,928 | $99.76 | $1.69M | 03 Nov 2025 | 04 Nov 2025 |
| Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology | Sale | 3,600 | $100.75 | $362.69K | 03 Nov 2025 | 04 Nov 2025 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Sale | 29,472 | $99.14 | $2.92M | 03 Nov 2025 | 04 Nov 2025 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Sale | 3,600 | $100.75 | $362.69K | 03 Nov 2025 | 04 Nov 2025 |
| Joseph Michael FitzgeraldEVP & Group Pres, Cardiology | Sale | 16,928 | $99.76 | $1.69M | 03 Nov 2025 | 04 Nov 2025 |
| Zane Ellen M | Sale | 2,901 | $102.24 | $296.60K | 28 Oct 2025 | 28 Oct 2025 |
| Ellen M ZaneDirector | Sale | 2,901 | $102.24 | $296.60K | 28 Oct 2025 | 28 Oct 2025 |
| Zane Ellen M | Sale | 9,990 | $101.13 | $1.01M | 27 Oct 2025 | 28 Oct 2025 |
| Ellen M ZaneDirector | Sale | 9,990 | $101.13 | $1.01M | 27 Oct 2025 | 28 Oct 2025 |
Frequently Asked Questions
What is BSX stock price today?
Boston Scientific Corp. (BSX) is currently trading at $62.82. The stock has a 52-week range of $62.00 to $108.14 and a market capitalization of $93.36B.
Is BSX a good stock to buy in 2026?
Boston Scientific Corp. has a P/E ratio of 32.4 (forward P/E: 16.1), a dividend yield of none, and 1-year performance of -36.2%. 7 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling BSX stock?
There have been 18 insider transactions for BSX in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has BSX stock performed over the past year?
Boston Scientific Corp. (BSX) has returned -36.2% over the past 12 months. The stock traded between $62.00 and $108.14 during this period, and is currently at $62.82.
Which hedge funds own BSX (Boston Scientific Corp.)?
7 tracked hedge funds currently hold BSX in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is BSX's market cap and valuation?
Boston Scientific Corp. (BSX) has a market capitalization of $93.36B. The trailing P/E ratio is 32.4 and forward P/E is 16.1. The stock is classified in the Healthcare sector.
What is BSX's revenue and profitability?
Boston Scientific Corp. reported revenue of $20.07B with net income of $2.90B and a profit margin of 0.14%. The stock has a beta of 0.78.
What sector is BSX in and who are its biggest institutional holders?
Boston Scientific Corp. (BSX) operates in the Healthcare sector. It is held by 7 tracked hedge funds. See the ownership table above for the complete list.